Ahn-Gook Pharmaceutical Co., Ltd. logo

Ahn-Gook Pharmaceutical Co., Ltd. (001540)

Market Open
15 Oct, 06:30 AM
KRX SM KRX SM
₩
9,670. 00
-180
-1.8274%
₩
129.22B Market Cap
- P/E Ratio
2,532% Div Yield
59,354 Volume
- Eps
₩ 9,850
Previous Close
Add Transaction
Day Range
9,550 9,810
Year Range
7,280 13,650
Want to track 001540 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ahn-Gook Pharmaceutical Co., Ltd. (001540) Statistics

Valuation metrics

Market Cap 129.22B
Enterprise value 141.84B
Trailing P/E (ttm) 17.28
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) 0.39
Price/Book (mrq) 0.76
Enterprise Value/Revenue 0.43
Enterprise Value/EBITDA 4.91

Overview

Shares outstanding 11.37M
Float 5.07M
Shares short -
% Held by insiders 0.48%
% Held by institutions 0%
Average volume (10 days) 604.54K
Average volume (90 days) 490.35K

Price summary

52-Week low 7,280
52-Week high 13,650
Beta 0.77
50-Day moving average 8,770.2
200-Day moving average 8,321.2

Dividends and splits

Forward annual dividend rate 2,532
Forward annual dividend yield 0.2227%
Trailing annual dividend rate 633
Trailing annual dividend yield 0.0557%
5-Year annual dividend yield 3.72%
Payout ratio 0.44
Dividend Date 5 Jan 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 1:1
Last split Date 29 Dec 2014

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.05%
Operating margin 0.16%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.1%

Income Statement

Revenue (ttm) 330.05B
Revenue per share (ttm) 29,053.35
Quarterly revenue growth (yoy) 0.31%
Gross profit (ttm) 218.13B
EBITDA 18.96B
Net income to common (ttm) 16.27B
Diluted EPS (ttm) 658
Quarterly earnings growth (yoy) 2.45%

Balance Sheet

Total cash (mrq) 66.34B
Total cash per share (mrq) 5,838.69
Total debt (mrq) 78.06B
Total Debt/Equity (mrq) 45.7
Current ratio (mrq) 1.62%
Book value per share (mrq) 15,034.2

Cash Flow

Cash flow statement 50.79B
Levered free cash flow (LFCF) 43.61B